About cs33ca: Haynes Darlington M.Sc. PharmD. (CCPE) joined the pharmaceutical industry in 1969. In 1982 he was assigned to the dental team to make submissions to regulatory agencies (FDA) and HC (Health Canada) to obtain acceptance for Articaine hcl into North America for Dental use as a local anesthetic. He is highly respected among peers in the field of pharmacology and bio-chemistry. In 1999, Haynes received The Team Excellence Award from The City of New York. The award recognized the value and professionalism of a continuing education program.
Local anesthesia is fundamental to dentistry. The goal at this site is to provide dentists with a review of the pharmacological and biochemical properties of commonly prescribed agents. Anecdotal evidence of local anesthesia failure is about 18 %. Our presentations will explain the possible complications of new medications and local anesthetics. How certain changes in our "life styles" such as the use of illicit compounds may be impacting on this upward trend. C E courses are ADA C.E.R.P Certified.
- New York City’s Oral Health, Programs and Policy. 1998
- Mid Winter Clinic (Chicago) 2002
- Ontario Dental Association (ODA) Convention.2002
- Jasper Dental Congress.2003
- NDA of Washington DC. 2004
- ACFD (Association of Canadian Faculties of Dentistry. 2005
- Haynes Darlington has attended many workshops on Local Anesthetics, with opinion leaders in the U. S. & Canada.
His major accomplish was gaining regulatory approval for Articaine Hcl in North America (1982) and its rapid growth internationally. His extensive knowledge of Biochemistry, Pharmacology and application methodology of local anesthetics, result clinically in fewer failures. You will find his lectures informative, proactive and stimulating. His lecture is sub-titled "Things they never taught me in dental school!" http://www.anestheticnews.com
E-Mail llocalanesthetics@yahoo.ca Telephone 905-597-5688
